Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex

被引:15
|
作者
Fohlen, Martine [1 ]
Ferrand-Sorbets, Sarah [1 ]
Delalande, Olivier [1 ]
Dorfmueller, Georg [1 ]
机构
[1] Fdn Ophtalmol A de Rothschild, Dept Pediat Neurosurg, Paris, France
关键词
Hydrocephalus; Ventriculoperitoneal shunt; Pediatric; Brain tumor; CONSENSUS CONFERENCE; INTRAVENTRICULAR TUMORS; DIAGNOSTIC-CRITERIA; CORTICAL DYSPLASIAS; RECOMMENDATIONS; MANAGEMENT; IDENTIFICATION; CLASSIFICATION; EVEROLIMUS; SPECTRUM;
D O I
10.1007/s00381-018-3826-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Subependymal giant cell astrocytomas (SEGAs) are low-grade intraventricular glial tumors that develop in 10-15% of patients with tuberous sclerosis complex; they often cause hydrocephalus and are potentially accessible to a surgical treatment. Our aim is to evaluate morbidity and results after surgery in symptomatic and asymptomatic patients. We present a retrospective series of 18 pediatric patients operated on for SEGA between 2006 and 2016 at our institution. We reviewed surgical indications, preoperative clinical and radiologic data, surgical management, and clinical and radiological follow-up. Mean age at surgery was 10.7 years. The surgical decision was based on clinical signs of raised intracranial pressure due to hydrocephalus in 8 and on radiological findings without any clinical signs in the other 10 patients (increased in SEGA volume with or without ventricular enlargement). Surgical treatment consisted in a frontal trans-ventricular microsurgical approach in 17 patients and an endoscopic approach in 1. External ventricular drainage was placed in all the patients but 1. Ventriculoperitoneal shunting (VPS) became necessary in 6 patients, all of them presenting with a preoperative active hydrocephalus. Morbidity appeared very low with meningitis occurring in 1 patient. Resection was complete in 15 children with no recurrence during a mean follow-up of 5.25 years and incomplete in 3 requiring a second surgery. Surgery of SEGA represents a very effective treatment with low morbidity and no mortality in the present series. In patients operated before the onset of clinical signs of hydrocephalus, internal VPS could be avoided whereas in others, an additional shunt surgery became necessary. This gives arguments in favor of a regular MRI surveillance in tuberous sclerosis complex patients with SEGA in order to best propose resective surgery once a growth of tumor and/or ventricular size have been confirmed but before raised intracranial pressure occurs.
引用
收藏
页码:1511 / 1519
页数:9
相关论文
共 50 条
  • [1] Surgery for subependymal giant cell astrocytomas in children with tuberous sclerosis complex
    Martine Fohlen
    Sarah Ferrand-Sorbets
    Olivier Delalande
    Georg Dorfmüller
    Child's Nervous System, 2018, 34 : 1511 - 1519
  • [2] The natural history of subependymal giant cell astrocytomas in tuberous sclerosis complex: a review
    Chan, Denise L.
    Calder, Tessa
    Lawson, John A.
    Mowat, David
    Kennedy, Sean E.
    REVIEWS IN THE NEUROSCIENCES, 2018, 29 (03) : 295 - 301
  • [3] Congenital subependymal giant cell astrocytomas in patients with tuberous sclerosis complex
    Kotulska, Katarzyna
    Borkowska, Julita
    Mandera, Marek
    Roszkowski, Marcin
    Jurkiewicz, Elzbieta
    Grajkowska, Wieslawa
    Bilska, Malgorzata
    Jozwiak, Sergiusz
    CHILDS NERVOUS SYSTEM, 2014, 30 (12) : 2037 - 2042
  • [4] Subependymal giant-cell astrocytomas in the absence of tuberous sclerosis
    Reynolds, Rebecca A.
    Aum, Diane J.
    Gonzalez-Gomez, Ignacio
    Wong, Michael
    Roberts, Kaleigh
    Dahiya, Sonika
    Rodriguez, Luis F.
    Roland, Jarod L.
    Smyth, Matthew D.
    JOURNAL OF NEUROSURGERY-PEDIATRICS, 2023, 32 (03) : 351 - 357
  • [5] Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex-Current Views on Their Pathogenesis and Management
    Gao, Chao
    Zabielska, Bernadeta
    Jiao, Fuyong
    Mei, Daoqi
    Wang, Xiaona
    Kotulska, Katarzyna
    Jozwiak, Sergiusz
    JOURNAL OF CLINICAL MEDICINE, 2023, 12 (03)
  • [6] Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Considerations for Surgical or Pharmacotherapeutic Intervention
    Wheless, James W.
    Klimo, Paul, Jr.
    JOURNAL OF CHILD NEUROLOGY, 2014, 29 (11) : 1562 - 1571
  • [7] Pharmacologic management of tuberous sclerosis complex-associated subependymal giant cell astrocytomas
    Franz, David Neal
    EXPERT OPINION ON ORPHAN DRUGS, 2014, 2 (01): : 53 - 66
  • [8] Current trends in the management of subependymal giant cell astrocytomas in tuberous sclerosis
    Frassanito, Paolo
    Noya, Carolina
    Tamburrini, Gianpiero
    CHILDS NERVOUS SYSTEM, 2020, 36 (10) : 2527 - 2536
  • [9] Beyond Benign: A Case of Subependymal Giant Cell Astrocytomas Provoking Hydrocephalus in Tuberous Sclerosis Complex
    Navarro-Ballester, Antonio
    Alvaro-Ballester, Rosa
    Lara-Martinez, Miguel Angel
    ACTA MEDICA LITUANICA, 2024, 31 (01) : 150 - 156
  • [10] Distinct DNA Methylation Patterns of Subependymal Giant Cell Astrocytomas in Tuberous Sclerosis Complex
    Bongaarts, Anika
    Mijnsbergen, Caroline
    Anink, Jasper J.
    Jansen, Floor E.
    Spliet, Wim G. M.
    den Dunnen, Wilfred F. A.
    Coras, Roland
    Bluemcke, Ingmar
    Paulus, Werner
    Gruber, Victoria E.
    Scholl, Theresa
    Hainfellner, Johannes A.
    Feucht, Martha
    Kotulska, Katarzyna
    Jozwiak, Sergiusz
    Grajkowska, Wieslawa
    Buccoliero, Anna Maria
    Caporalini, Chiara
    Giordano, Flavio
    Genitori, Lorenzo
    Soylemezoglu, Figen
    Pimentel, Jose
    Jones, David T. W.
    Scicluna, Brendon P.
    Schouten-van Meeteren, Antoinette Y. N.
    Muhlebner, Angelika
    Mills, James D.
    Aronica, Eleonora
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 2022, 42 (08) : 2863 - 2892